Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Acrodermatitis enteropathica can be linked to dental issues, so thorough dental exams are important.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Tofacitinib is an effective and safe treatment for alopecia areata.

Etretinate treatment changed hair growth patterns in many patients.

Two mutations in KRT74 and EDAR genes cause sheep to have finer wool.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

ECM components regulate β-Catenin activity, affecting wound healing.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Tofacitinib may work better than methotrexate for treating moderate-to-severe alopecia areata.

Polyethylene alanine caused hair loss in young lab animals but not in adults, with hair regrowth occurring within 20 days.

PADI4 enzyme slows down cell growth in developing hair follicles.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Ritlecitinib effectively regrows hair in treatment-resistant alopecia areata with mild side effects.